美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CAR-T

1,730.74

-3.1686-0.18%

漲家數：1

跌家數：1

平家數：- -

市盈率：- -

高：1,732.48

開：1,732.01

低：1,705.45

收：1,733.91

成交量：690.32萬

成交額：9.89億

市值：4,459.98億

流通市值：4,377.29億

資料載入中...

總覽新聞資訊

諾華股價在TRADEGATE平台上較昨日蘇黎世收盤價下跌5.1%。

諾華DM1藥物III期臨床試驗未達到主要終點

繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗

諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。

諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力

一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」

諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。

諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標

通用電氣維諾華公司：與愛爾蘭國家電力公司達成協議，將為蘇格蘭高地的96兆瓦奇倫塞德風電場供應16台6.1兆瓦-158米型

諾華公司：計劃停止克萊因巴塞爾生產基地的生產可能導致約130個工作崗位流失。所有計劃中的變更均需經過信息告知與協商程序。

諾華集團：高效口服BTK抑制劑瑞米布替尼在III期RMS臨床試驗中顯著降低複發率安全性表現良好

諾華製藥（NVS）漲6% 在BTK抑制劑賽道迎來重要突破

美股異動 | 諾華製藥升逾5%，MS口服藥後期試驗告捷

諾華製藥(NVS)股票9月1日盤中上漲6.54%：真相來了

TradingKey中文

諾華製藥(NVS.US)神經免疫管線「悲喜交加」：患者死亡致CAR-T臨床試驗暫停 MS口服藥後期試驗告捷

諾華暫停該項目，此前已報告3起嚴重的免疫效應細胞相關噬血細胞綜合徵病例，併發症最終導致患者死亡。

諾華：出現死亡病例，暫停自身免疫細胞療法相關研究

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK4578/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1730.7407,"timestamp":1789502399999,"preClose":1733.9093,"halted":0,"volume":6903229,"delay":0,"changeRate":-0.001827,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-3.168579,"latestTime":"09-15 16:00:00 EDT","open":1732.0104,"high":1732.4797,"low":1705.446,"amount":988711146.759969,"amplitude":0.015591,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.300443,"peRate":46.548588,"turnoverRate":0.002235,"increases":0,"decrements":2,"flats":0,"marketCap":445998383104,"floatMarketCap":437728854016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1732.4797,"amplitude":0.015591,"preClose":1733.9093,"low":1705.446,"pbRate":"8.300443","latestPrice":1730.7407,"volume":6903229,"delay":0,"open":1732.0104,"prevYearClose":1612.5378,"prevWeekClose":1707.2908,"prevMonthClose":1830.2803,"prevQuarterClose":1768.1697,"fiveDayClose":1725.5667,"twentyDayClose":1794.044,"sixtyDayClose":1684.6451,"secType":"PLATE","market":"US","turnoverRate":0.002235,"peRate":46.548588,"marketCap":445998383104,"floatMarketCap":437728854016,"timestamp":1789502399999,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665342698","title":"諾華股價在TRADEGATE平台上較昨日蘇黎世收盤價下跌5.1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342698","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342698?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:42","pubTimestamp":1788846169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0320765489.SGD","IE00B2B36J28.USD","LU0070302665.USD","LU0208291251.USD","BK4007","BK4585","NVS","IE0002141913.USD","LU0211331839.USD","BK4588","BK4532","IE00BFTCPJ56.SGD","MEDX","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","PPH","IE00BJJMRZ35.SGD","BK4578","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342373","title":"諾華DM1藥物III期臨床試驗未達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:31","pubTimestamp":1788845477,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["PPH","BK4588","BK4578","LU0070302665.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IBBQ","BMED","PSYK","NVS","MDTX","BK4585","IBBJ","IE00BJT1NW94.SGD","BK4532","IE00BJJMRZ35.SGD","BK4007","IE00B2B36J28.USD","LU0320765489.SGD","LU0208291251.USD","IE0009355771.USD","LU0211331839.USD","IE0002141913.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665831989","title":"繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665831989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665831989?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:10","pubTimestamp":1788779458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0002141913.USD","BK4585","BMED","LU0211331839.USD","BK4532","MDTX","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4588","BK4578","IE00B4R5TH58.HKD","MEDX","IBBQ","IE00B2B36J28.USD","LU0320765489.SGD","BGIA","IBBJ","PPH","PSYK","LU0070302665.USD","BK4007","NVS","LU0208291251.USD","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397441","title":"諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397441","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397441?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:42","pubTimestamp":1788766955,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","NVS","IE00BFTCPJ56.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","BK4007","IE0002141913.USD","MEDX","IE00B2B36J28.USD","IE0009355771.USD","BK4585","LU0320765489.SGD","BK4532","BK4578","LU0208291251.USD","BK4588","PPH","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739206","title":"諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739206","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:24","pubTimestamp":1788765896,"startTime":"0","endTime":"0","summary":"诺华股价下跌，因一项胆固醇药物研究失败加剧了研发管线压力路透伦敦9月7日-诺华公司的股价周一早盘下跌3.3%，此前该公司的一款降胆固醇药物在一项备受关注的研究中未能达到预期效果，这使得该疗法再次受到质疑，同时也提高了这家瑞士制药商即将公布的基因疗法数据所面临的压力。上周五晚间，诺华表示，在其针对高Lp 患者进行的一项大型晚期研究中，其药物佩拉卡森  未能降低心脏病发作和中风的风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","BK4585","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4578","PPH","BK4532","LU0211331839.USD","BK4588","IE00B4R5TH58.HKD","NVS","IE0009355771.USD","LU0070302665.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","MEDX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1571399168.USD","LU2242646821.SGD","LU2468319806.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","BK4139","PJP","BK4007","LU2112291526.USD","BK4533","MEDX","PBE","LU0058720904.USD","IE00B4R5TH58.HKD","NVS","LU0208291251.USD","BIB","SG9999001440.SGD","LU0122379950.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK4566","BK4534","LU0109394709.USD","LU0320765992.SGD","AMGN","LU0868494617.USD","BBH","IBBQ","PPH","LU1023059063.AUD","IE00B2B36J28.USD","BK4532","BK4585","BK4578","IE0009355771.USD","IE0002141913.USD","LU2242652126.USD","IE00BJT1NW94.SGD","BK4581","LU0320765489.SGD","LU0070302665.USD","LU0289739699.SGD","LU0211331839.USD","BK4588","LU0889565916.HKD","IBB","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394493","title":"諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394493","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394493?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:30","pubTimestamp":1788762634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","MEDX","BK4588","IE0002141913.USD","LU0208291251.USD","BK4585","LU0320765489.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4532","LU0070302665.USD","IE0009355771.USD","BK4007","PPH","BK4009","BK4578","IE00B2B36J28.USD","BAOS","NVS","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394397","title":"諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394397?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:11","pubTimestamp":1788761471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","LU0208291251.USD","IE00B2B36J28.USD","LU0306806265.USD","LU0320765489.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0225771236.USD","SG9999011175.SGD","IE00BJT1NW94.SGD","NVS","SG9999003800.SGD","BK4532","BK4599","PPH","LU0868494617.USD","IE0002141913.USD","BK4534","IE0002270589.USD","SG9999013999.USD","IE00B4R5TH58.HKD","MEDX","BK4533","IE00BLSP4452.SGD","BK4592","PFE","SG9999002224.SGD","LU0122379950.USD","IE000M9KFDE8.USD","LU0234572021.USD","BK4007","BK4581","SG9999001176.SGD","LU0456855351.SGD","BK4588","LU0070302665.USD","LU1894683348.USD","LU0225284248.USD","LU0211331839.USD","LU0985481810.HKD","IE00BLSP4239.USD","LU0321505868.SGD","LU0289739699.SGD","BK4550","LU0058720904.USD","LU0170899867.USD","LU0306807586.USD","LU1894683264.USD","BK4585","IE00BBT3K403.USD","SG9999001176.USD","LU1023059063.AUD","OZEM","IE00B19Z3581.USD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","BK4568","LU1066051498.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","SGXZ57979304.SGD","LU1057294990.SGD","LU1883839398.USD","IE0009355771.USD","LU2596442595.SGD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664694879","title":"通用電氣維諾華公司：與愛爾蘭國家電力公司達成協議，將為蘇格蘭高地的96兆瓦奇倫塞德風電場供應16台6.1兆瓦-158米型","url":"https://stock-news.laohu8.com/highlight/detail?id=2664694879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664694879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:17","pubTimestamp":1788434237,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0208291251.USD","LU0070302665.USD","IE00B2B36J28.USD","PPH","IE00BFTCPJ56.SGD","NVS","LU0320765489.SGD","BK4585","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","BK4532","BK4007","LU0211331839.USD","IE0009355771.USD","MEDX","IE0002141913.USD","BK4588","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811784","title":"諾華公司：計劃停止克萊因巴塞爾生產基地的生產可能導致約130個工作崗位流失。所有計劃中的變更均需經過信息告知與協商程序。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811784","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811784?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:37","pubTimestamp":1788352638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","MEDX","BK4588","IE0002141913.USD","LU0208291251.USD","BK4585","LU0320765489.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4532","LU0070302665.USD","IE0009355771.USD","BK4007","PPH","BK4578","IE00B2B36J28.USD","NVS","HELS","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815045","title":"諾華集團：高效口服BTK抑制劑瑞米布替尼在III期RMS臨床試驗中顯著降低複發率 安全性表現良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815045","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815045?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:11","pubTimestamp":1788347485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BMED","IBBQ","IE0009355771.USD","BK4007","PPH","NVS","LU0211331839.USD","LU0070302665.USD","IE00B2B36J28.USD","MEDX","BK4532","IE00BJT1NW94.SGD","IE0002141913.USD","PSYK","IE00BJJMRZ35.SGD","BK4578","MDTX","IE00B4R5TH58.HKD","BK4588","LU0208291251.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664850928","title":"諾華製藥（NVS）漲6% 在BTK抑制劑賽道迎來重要突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2664850928","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664850928?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 23:18","pubTimestamp":1788275914,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺华制药 早盘股价扬升，最新涨6%，报161.2美元，成交额3.2亿美元。诺华周二公布，对比对照药物特立氟胺，瑞米布替尼可降低患者疾病复发率，减少脑部病灶数量，试验中未观察到肝脏相关安全风险。该药有望成为诺华重磅产品Kesimpta的后续迭代品种，同时印证BTK抑制剂在抑制异常免疫反应方面的治疗潜力。诺华计划向全球监管机构提交瑞米布替尼治疗多发性硬化症的上市申请，完整临床数据将于今年晚些时候在多伦多医学会议对外披露。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/YmFmZjgzNDhkMjgxZmE5MWVmYzk4MzgzNTg2ODExODg1NTU0MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YmFmZjgzNDhkMjgxZmE5MWVmYzk4MzgzNTg2ODExODg1NTU0MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","BK1191","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK1574","NVS","LU0208291251.USD","BK4585","BK4532","IE00BJT1NW94.SGD","BK4588","PPH","01477","IE0002141913.USD","BK4007","BK4578","IE00BJJMRZ35.SGD","MEDX","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664016854","title":"美股異動 | 諾華製藥升逾5%，MS口服藥後期試驗告捷","url":"https://stock-news.laohu8.com/highlight/detail?id=2664016854","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664016854?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:35","pubTimestamp":1788273301,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，诺华制药涨逾5%，报160.82美元。消息面上，诺华表示，试验显示，接受瑞米布替尼治疗的患者与接受特立氟胺治疗的患者相比，复发率和脑部病变数量均有所减少，且未观察到肝脏安全信号。该药有望为诺华提供一种治疗多发性硬化症的新型口服药物，并成为其重磅产品Kesimpta系列的后续产品。此前，赛诺菲和默克公司的类似药物在后期试验中未能在复发率指标上优于特立氟胺。","market":"us","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490652.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺华制药MS口服药后期试验告捷","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IE00BFTCPJ56.SGD","BK4532","IE00B4R5TH58.HKD","NVS","BK1191","IE0002141913.USD","PPH","LU0211331839.USD","BK4007","LU0320765489.SGD","BK4578","IE00BJT1NW94.SGD","MEDX","LU0208291251.USD","BK1574","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4585","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664524478","title":"諾華製藥(NVS)股票9月1日盤中上漲6.54%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2664524478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664524478?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:16","pubTimestamp":1788272176,"startTime":"0","endTime":"0","summary":"• Remibrutinib 在三期多发性硬化症试验中取得成功，展现出临床优效性。\n• 在三名患者死亡后，诺华暂停了八项早期 CAR-T 试验。\n• 该公司报告年收入为 563.3 亿美元，净利润为 139.8 亿美元。","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262144173-market-movers-nvs-20260901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","BK1574","IE00BJJMRZ35.SGD","NVS","01477","BK4007","BK4588","LU0211331839.USD","IE00BFTCPJ56.SGD","MEDX","PPH","BK4578","BK1191","LU0070302665.USD","BK4532","IE0009355771.USD","IE0002141913.USD","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831619","title":"諾華製藥(NVS.US)神經免疫管線「悲喜交加」：患者死亡致CAR-T臨床試驗暫停 MS口服藥後期試驗告捷","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831619?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:40","pubTimestamp":1788248407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药在神经与自身免疫领域迎来“冰火两重天”：公司因三名患者死亡紧急叫停八项CAR-T疗法临床试验;不过，其多发性硬化症口服药remibrutinib在后期临床试验中取得积极结果。CAR-T试验紧急暂停诺华制药在8月底暂停了八项针对自身免疫和神经系统疾病的实验性疗法临床试验，此前有三名患者死亡。诺华制药发言人表示，公司正在“对所观察到的安全事件进行全面审查”，并将这种致命免疫反应描述为CAR-T疗法中已知的安全风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSYK","BK4578","MDTX","BK1191","MEDX","BMED","01477","IE00B2B36J28.USD","BK1574","IE00BFTCPJ56.SGD","BK4532","BK4588","LU0320765489.SGD","LU0070302665.USD","IE00B4R5TH58.HKD","BK4585","LU0208291251.USD","IE00BJT1NW94.SGD","IE0002141913.USD","PPH","IE0009355771.USD","IE00BJJMRZ35.SGD","NVS","LU0211331839.USD","BK4007","IBBQ","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664839602","title":"諾華暫停該項目，此前已報告3起嚴重的免疫效應細胞相關噬血細胞綜合徵病例，併發症最終導致患者死亡。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664839602","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664839602?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:23","pubTimestamp":1788247409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","LU0211331839.USD","IE00B2B36J28.USD","BK4585","NVS","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0208291251.USD","BK4588","LU0070302665.USD","BK4007","IE0009355771.USD","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","MEDX","PPH","BK4532","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800188","title":"諾華：出現死亡病例，暫停自身免疫細胞療法相關研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800188","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800188?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 12:21","pubTimestamp":1788236460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WDNA","IE00B2B36J28.USD","IE00B4R5TH58.HKD","CNCR","LU0320765489.SGD","NVS","BK4588","MEDX","BK4578","BK4532","LU0070302665.USD","LU0211331839.USD","BK4007","IE00BJT1NW94.SGD","BK4585","LU0208291251.USD","IE00BFTCPJ56.SGD","SYNB","IE00BJJMRZ35.SGD","PPH","IE0002141913.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}]}}